|Day Low/High||2.71 / 2.80|
|52 Wk Low/High||1.99 / 5.05|
We initiated a new position and added to a couple of others as we closed the books on the second quarter.
REDWOOD CITY, Calif., July 1, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
Last week we started two new positions, trimmed a winner and exited another name as the markets moved higher across the board.
With the market rising last week, we saw favorable action in several of our holdings and booked some hefty gains in one name.
With the market rebounding, the majority of our positions rose week over week.
During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.
REDWOOD CITY, Calif., June 3, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
Several positive moves along with our cash position helped insulate the overall portfolio’s performance from last week's market decline.
Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX options chain for the new July 19th contracts and identified the following put contract of particular interest.
Amid renewed trade and geopolitical tensions, we trimmed our position in Energy Recovery and added a short-term trade in J.C. Penney.
We took some nice profits trimming a position, exited a name and added to another holding during a challenging week for stocks.
REDWOOD CITY, Calif., May 8, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
We added to three positions and pulled the plug on another during a solid week for small-cap stocks.
We ditched one position and added to another last week as small-cap stocks trended higher.
Investors in AcelRx Pharmaceuticals Inc saw new options become available this week, for the December 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
REDWOOD CITY, Calif., April 25, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
During the week, we took a starter position in Encana Corp. and boosted our cash position by trimming iShares Russell 2000 ETF.
We made several trades last week as the overall market grinded modestly higher.
REDWOOD CITY, Calif., April 11, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
The portfolio had a strong start to the June quarter, due in part to the small cap-heavy Russell 2000 leading the market higher.
Last week was a very strong one for many of our positions as the domestic market ended the first quarter on a high note.
During the week we brought Fitbit back into the portfolio and added Digital Turbine to the Bullpen.
Last week was a very good one for the portfolio as nine of our 13 holdings outperformed our benchmark, the Russell 2000.
We initiated one position and exited another during a tough week for small-cap stocks.
REDWOOD CITY, Calif., March 11, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
Is action required for AcelRx Pharmaceuticals and Energy Recovery?
- DSUVIA now available for use in certified medically supervised healthcare settings, with initial shipments to wholesalers completed in the second half of February 2019
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.